Small-cap biotechnology stocks offer some of the most breathtaking opportunities in the market, but some are better than others. For example, these three tiny biotech stocks are favorites among our Motley Fool experts, and that could mean they’re worth watching.Source: Portola Pharmaceuticals.: Warfarin’s decades long dominance as an anticoagulant used to treat heart disease and post-operative patients is waning, and […]
Source: Gilead Sciences.Gilead Sciences surprised investors when it recently announced that it will begin returning some of its cash stockpile to investors in the form of a dividend. Since dividend-paying biotech stocks are a bit of a rarity, we asked two Motley Fool healthcare experts for their opinion on whether Gilead Sciences’ dividend plan makes sense. Read on to learn […]
Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case they’re material to our investing thesis.The market’s best-performing companies last week included three healthcare stocks that won over investors with can’t-miss news. Two of these companies are highly speculative, emerging-stage biotech stocks that […]
Source: Flickr user Simon & His Camera .Love is in the air, and that makes it the perfect time to confess my affection for three large-cap biotech stocks that market a slate of highly profitable, market-share leading therapies. Read on to learn more about why I have fallen for each of them.No. 1: Celgene CorporationWhile other companies hem and haw […]
Hepatitis C treatment has progressed by leaps and bounds in the past few years, and appears to be accelerating even more quickly now. Cure rates have increased, treatment times are plummeting, and side effects are falling away. Is now the time to jump into the biotechs researching new drugs?Industry Focus takes a look at Regulus Therapeutics and Achillion Pharmaceuticals […]
Not many investment pros managed to dump their oil stocks before the price of crude started plummeting last year, but prescient investors who did obviously escaped heavy losses. The big question: Where did they invest the proceeds for greater future gains?One top-ranked money manager, Graham Tanaka, president and senior analyst and portfolio manager at TANAKA Growth Fund (TGFRX), was one […]
View photo.Biotech stocks have performed well in the recent bull market.Since January 1, 2008, the SPDR S&P Biotech ETF (NYSE: XBI) has outperformed the SPDR S&P 500 ETF Trust (NYSE: SPY), gaining 233 percent compared with just 41.3 percent gains in SPY.Analysts at Sterne Agee took a closer look at three active biotech companies in separate notes Friday morning.Molina Healthcare, […]
In a repeat of a dynamic that dominated trading early last year, investors piled into stocks Thursday as Russia signed up for another cease-fire deal in Ukraine while negotiations between Greece and the European establishment suddenly became less acrimonious. While no deal has been announced, the bureaucrats have been making noises about agreeing to the outlines of an agreement which, […]
98 Up Last Year And 22 Winning Trades In A Row, Business / Investing
Select LanguageEnglishAfrikaansAlbanianArabicBelarusianBulgarianCatalanChinese (Simplified)Chinese (Traditional)CroatianCzechDanishDutchEstonianFilipinoFinnishFrenchGalicianGermanGreekHebrewHindiHungarianIcelandicIndonesianIrishItalianJapaneseKoreanLatvianLithuanianMacedonianMalayMalteseNorwegianPersianPolishPortugueseRomanianRussianSerbianSlovakSlovenianSpanishSwahiliSwedishThaiTurkishUkrainianVietnameseWelshYiddish
We have 56 guests online
Taken from:
98 Up Last Year And 22 Winning Trades In A Row, Business / Investing #Business #Investing
See which stocks are being affected by Social Media
[…]
Biotechnology indices have been on a rapid ascent for three years, and 2015 appears to be off to the races as well. Bloom Burton & Co.’s David Martin has taken his seat in the grandstands, betting on specialty pharma and one day delivery cialis biotech companies based in Canada, where resource stocks have absorbed so much investment capital that […]
